Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Free radical research

• Publication date

  1996-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3109/10715769609088005PMID 8845917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Superoxide‐dependent depletion of reduced glutathione by L‐DOPA and dopamine. Relevance to Parkinson's disease

  1995cited by this paper
• Nutrition and health aspects of free radicals and antioxidants.

  1994cited by this paper
• Inhibition of human glutathione S-transferases by dopamine, alpha-methyldopa and their 5-S-glutathionyl conjugates.

  1994cited by this paper
• Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain

  1994cited by this paper
• Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation.

  1994cited by this paper
• Differential effects of chronic L-dopa treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine.

  1994cited by this paper
• Intense oxidative DNA damage promoted by l‐DOPA and its metabolites implications for neurodegenerative disease

  1994cited by this paper
• Oxidative stress, glutamate, and neurodegenerative disorders.

  1993cited by this paper
• A radical hypothesis for neurodegeneration.

  1993cited by this paper
• Free radicals and their scavengers in Parkinson's disease.

  1993cited by this paper
• The possible role of iron in the etiopathology of parkinson's disease

  1993cited by this paper
• Free radicals, antioxidants, and human disease: where are we now?

  1992cited by this paper
• Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+.

  1992cited by this paper
• Biochemical and toxicological properties of the oxidation products of catecholamines.

  1992cited by this paper
• Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid.

  1992cited by this paper
• Reactive Oxygen Species and the Central Nervous System

  1992cited by this paper
• DNA damage by oxygen‐derived species Its mechanism and measurement in mammalian systems

  1991cited by this paper
• Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease

  1991cited by this paper
• Oxidative stress as a cause of Parkinson's disease

  1991cited by this paper
• Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone.

  1991cited by this paper
• Metal-catalyzed oxidation of proteins. Physiological consequences.

  1991cited by this paper
• Dopa and dopamine cause cultured neuronal death in the presence of iron.

  1991cited by this paper
• How to characterize a biological antioxidant.

  1990cited by this paper
• In Vivo Autoxidation of Dopamine in Guinea Pig Striatum Increases with Age

  1990cited by this paper
• Dopamine turnover and glutathione oxidation: implications for Parkinson disease.

  1989cited by this paper
• Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

  1989cited by this paper
• Tissue destruction by neutrophils.

  1989cited by this paper
• Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.

  1989cited by this paper
• Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

  1989cited by this paper
• A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brainstem.

  1988cited by this paper
• Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione.

  1988cited by this paper
• Action of lead(II) and aluminium (III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions.

  1988cited by this paper
• Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase.

  1987cited by this paper
• The deoxyribose method: a simple "test-tube" assay for determination of rate constants for reactions of hydroxyl radicals.

  1987cited by this paper
• Monoamine oxidase, hydrogen peroxide, and Parkinson's disease.

  1987cited by this paper
• The antioxidant action of human extracellular fluids. Effect of human serum and its protein components on the inactivation of alpha 1-antiproteinase by hypochlorous acid and by hydrogen peroxide.

  1987cited by this paper
• Mechanism of Kainate Toxicity to Cerebellar Neurons In Vitro Is Analogous to Reperfusion Tissue Injury

  1987cited by this paper
• Reactivity of HO2/O−2 Radicals in Aqueous Solution

  1985cited by this paper
• L-DOPA esters as potential prodrugs. I: Physicochemical properties

  1985cited by this paper
• 3 – Organic Peroxy Free Radicals as Ultimate Agents in Oxygen Toxicity

  1985cited by this paper
• Oxygen radicals and the nervous system

  1985cited by this paper
• Use of desferrioxamine as a 'probe' for iron-dependent formation of hydroxyl radicals. Evidence for a direct reaction between desferal and the superoxide radical.

  1985cited by this paper
• Oxygen toxicity, oxygen radicals, transition metals and disease.

  1984cited by this paper
• Genetic toxicity of dopamine.

  1983cited by this paper
• Mechanism of the oxidation of dopamine by the hydroxyl radical in aqueous solution

  1983cited by this paper
• Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.

  1978cited by this paper
• Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

  1969cited by this paper
• A quantitative study on the nigro-neostriatal dopamine neuron system in the rat.

  1966cited by this paper

• Nephroprotective Effect of Mucuna pruriens, Moringa oleifera, and Milk Thistle Extracts against Acetaminophen-Induced Acute Kidney Injury in Mice

  2025cites this paper
• Levodopa exposure and nigral neuroinflammation in parkinsonian disorders: A postmortem study of 63 cases

  2025cites this paper
• Liquiritin and L-Dopa mitigate gaseous elemental mercury toxicity in Tillandsia usneoides: Insights into metabolic reprogramming and phytoremediation potential.

  2025cites this paper
• Nanostructures based on gold and silica as a delivery platform for enhanced L-DOPA therapy in neurodegenerative disease.

  2025cites this paper
• Effect of Phytoregulatory Substances on Adventitious Rooting of Grapevine Rootstock Paulsen 1103 Cuttings Under Hydroponic Conditions

  2025cites this paper
• Precision Interdiction of α-Synuclein Folding Pathways by Molecular Tweezers.

  2025cites this paper
• How to Design Catechol-Containing Hydrogels for Cell Encapsulation Despite Catechol Toxicity.

  2023cites this paper
• Biosynthesis of ZnO Nanoparticles Using the Aqueous Extract of Mucuna pruriens (utilis): Structural Characterization, and the Anticancer and Antioxidant Activities

  2023cites this paper
• Chromatography-mass spectrometry based chemical profiling of Mucuna pruriens (L.) DC. and its beneficial effect against hydrogen peroxide-induced oxidative stress in HEK 293T cells and breast cancer cells

  2023cites this paper
• Dopamine Inhibits Arabidopsis Growth through Increased Oxidative Stress and Auxin Activity

  2023cites this paper
• Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies

  2023cites this paper
• Variability in the Beneficial Effects of Phenolic Compounds: A Review

  2022cites this paper
• Impairment of neuronal mitochondrial function by l-DOPA in the absence of oxygen-dependent auto-oxidation and oxidative cell damage

  2021cites this paper
• L-DOPA and Dopamine in Plant Metabolism

  2020cites this paper
• Intracerebroventricular administration of dopamine in Parkinson's disease: treatment of motor fluctuations and dyskinesia

  2020cites this paper
• Combining the lack of chromogranins with chronic L-DOPA treatment affects motor activity in mice

  2020cites this paper
• New insights on neurotransmitters signaling mechanisms in plants

  2020cites this paper
• Modulation of Apoptotic Cell Death and Neuroprotective Effects of Glutathione—L-Dopa Codrug Against H2O2-Induced Cellular Toxicity

  2019cites this paper
• Polyamines in Parkinson’s Disease: Their Role in Oxidative Stress Induction and Protein Aggregation

  2019cites this paper
• In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies

  2019cites this paper
• Aroclor 1254 and BDE-47 inhibit dopaminergic function manifesting as changes in locomotion behaviors in zebrafish embryos.

  2018cites this paper
• Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress

  2017cites this paper
• FORMULATION AND CHARACTERIZATION OF POLY(β-AMINO ESTER) NETWORKS FOR CONTROLLED DELIVERY OF ANTIOXIDANTS IN PHARMACEUTICAL APPLICATIONS

  2017cites this paper
• ANTIOXIDANT AND ANTIBACTERIAL PROPERTIES OF CUTTLEFISH INK COLLECTED FROM SELECTED CUTTLEFISH LANDED

  2017cites this paper
• STUDIES ON BILIRUBIN CLEARANCES OF METHANOLIC LEAF OF VELVET BEANS (Mucuna pruriens) ON CCl4 INDUCED ALBINO RATS

  2017cites this paper
• In Vitro Cellular Assays for Oxidative Stress and Biomaterial Response

  2016cites this paper
• Elucidation of the interplay between Fe(II), Fe(III), and dopamine with relevance to iron solubilization and reactive oxygen species generation by catecholamines

  2016cites this paper
• A comprehensive review of amyotrophic lateral sclerosis

  2015cites this paper
• Betalain induction by l-DOPA application confers photoprotection to saline-exposed leaves of Disphyma australe.

  2015cites this paper
• In vivo and in vitro characterization of gastrointestinal dysmotility in the 6-OHDA rat model of Parkinson's disease

  2015cites this paper
• Inhibitory Effects of Caffeic Acid on Free-Radical Formation

  2015cites this paper
• Evaluation of Levodopa and Carbidopa Antioxidant Activity in Normal Human Lymphocytes In Vitro: Implication for Oxidative Stress in Parkinson’s Disease

  2015cites this paper
• Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease

  2015cites this paper
• The role of L-DOPA in plants.

  2014cites this paper
• The effects of dopamine on antioxidant enzymes activities and reactive oxygen species levels in soybean roots

  2014influential citation
• The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease.

  2014cites this paper
• Maladaptive Plasticity in Levodopa-Induced Dyskinesias and Tardive Dyskinesias: Old and New Insights on the Effects of Dopamine Receptor Pharmacology

  2014cites this paper
• The role of L-DOPA in plants

  2014cites this paper
• Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons

  2014cites this paper
• Cypermethrin-Induced Nigrostriatal Dopaminergic Neurodegeneration Alters the Mitochondrial Function:A Proteomics Study

  2014cites this paper
• 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an Endogenous Neurotoxic Compound, Disturbs the Behavioral and Biochemical Effects of l-DOPA: In Vivo and Ex Vivo Studies in the Rat

  2014cites this paper
• Influence of Therapy on Some Important Final Products of Oxidation of Lipids, Proteins and Nucleic Acids in Patients with Parkinson’s Diseases

  2014cites this paper
• Cu(II) and dopamine bind to α‐synuclein and cause large conformational changes

  2014cites this paper
• Effects of antiparkinsonian agents on β‐amyloid and α‐synuclein oligomer formation in vitro

  2013cites this paper
• Evidence of oxidative stress in young and aged DJ‐1‐deficient mice

  2013cites this paper
• In vitro antioxidant, analgesic and cytotoxic activities of Sepia officinalis ink and Coelatura aegyptiaca extracts

  2013cites this paper
• Breaking away from dopamine deficiency: an essential new direction for Parkinson’s disease

  2012cites this paper
• The Magic Velvet Bean of Mucuna pruriens

  2012cites this paper
• Parkinson disease: The controversy of levodopa toxicity in Parkinson disease

  2011cites this paper
• Caffeic acid inhibits the formation of 1-hydroxyethyl radical in the reaction mixture of rat liver microsomes with ethanol partly through its metal chelating activity

  2011cites this paper
• Effect of some naturally occurring iron ion chelators on the formation of radicals in the reaction mixtures of rat liver microsomes with ADP, Fe3+ and NADPH

  2011cites this paper
• The Allelochemical L-DOPA Increases Melanin Production and Reduces Reactive Oxygen Species in Soybean Roots

  2011cites this paper
• S-Glutathionylation: From Molecular Mechanisms to Health Outcomes

  2011cites this paper
• Phytochemical metabolites and their effects on in vitro and in vivo measures of oxidative stress

  2011cites this paper
• The neurochemical consequences of aromatic L-amino acid decarboxylase deficiency

  2011cites this paper
• Is levodopa toxic?

  2011cites this paper
• Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity.

  2011cites this paper
• L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?

  2011influential citation
• Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.

  2010cites this paper
• Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease.

  2010cites this paper
• Antioxidant Nanoparticles as Delivery Systems

  2010influential citation
• Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.

  2009cites this paper
• Melatonin inhibits 6‐hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents

  2009cites this paper
• MAO-B inhibitor know-how

  2009cites this paper
• Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease

  2009cites this paper
• Establishing the probable mechanism of L-DOPA in Alzheimer's disease management.

  2009cites this paper
• Chapter 2 – Nutritional Supplements and Functional Foods: Functional Significance and Global Regulations

  2008cites this paper
• Nutritional Supplements and Functional Foods: Functional Significance and Global Regulations

  2008cites this paper
• Dopaminergic neuron-specific oxidative stress caused by dopamine itself.

  2008cites this paper
• Protection against Parkinson’s disease progression: Clinical experience

  2008cites this paper
• Misincorporation of amino acid analogues into proteins by biosynthesis.

  2008cites this paper
• Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process

  2008cites this paper
• Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disorders.

  2008cites this paper
• Synthesis and study of L-dopa-glutathione codrugs as new anti-Parkinson agents with free radical scavenging properties.

  2007cites this paper
• Anti‐fibrillogenic and fibril‐destabilizing activities of anti‐Parkinsonian agents for α‐synuclein fibrils in vitro

  2007cites this paper
• Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases.

  2007cites this paper
• Dopamine and iron mediated fragmentation of galactocerebroside and cardiolipin in micelles

  2007cites this paper
• L-Dopa (L-3,4-Dihydroxyphenylalanine): A Non-Protein Toxic Amino Acid in Mucuna pruriens Seeds

  2007cites this paper
• α-Synuclein Aggregation and Parkinson’s Disease

  2007cites this paper
• Antioxidant properties of flaxseed lignans using in vitro model systems

  2006cites this paper
• Neuroprotection for Parkinson's disease.

  2006cites this paper
• Lipid peroxidation associated cardiolipin loss and membrane depolarization in rat brain mitochondria.

  2006cites this paper
• Pharmacotherapy for Parkinson’s disease: Current options, promising future therapies

  2006cites this paper
• Inhibition of mitochondrial complex II affects dopamine metabolism and decreases its uptake into striatal synaptosomes.

  2006cites this paper
• Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's beta-amyloid fibrils in vitro.

  2006cites this paper
• Apomorphine-induced myocardial protection is due to antioxidant and not adrenergic/dopaminergic effects.

  2006cites this paper
• Effect of dopamine on rat diaphragm apoptosis and muscle performance

  2006cites this paper
• Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro

  2006cites this paper
• L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties.

  2006cites this paper
• [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].

  2005cites this paper
• Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats.

  2005cites this paper
• Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase.

  2005cites this paper
• Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.

  2004cites this paper
• The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils*

  2004cites this paper
• Dopamine and L‐dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease

  2004cites this paper
• Levodopa in the treatment of Parkinson's disease: Current controversies

  2004cites this paper
• The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils.

  2004cites this paper
• An endogenous metabolite of dopamine, 3,4-dihydroxyphenylethanol, acts as a unique cytoprotective agent against oxidative stress-induced injury.

  2004cites this paper
• Clinical trials of neuroprotection for Parkinson’s disease

  2004cites this paper
• Dopamine neurotoxicity: age-dependent behavioral and histological effects.

  2003cites this paper